Navigation Links
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Date:11/5/2009

529) $(13,214) $(51,979) ======= ======= ======== ======== ======== Basic and diluted net loss per common share $(0.05) $(0.07) $(0.16) $(0.17) $(1.14) ====== ====== ====== ====== ====== Shares used in computing basic and diluted net loss per share 76,436 76,363 76,388 76,350 45,444 ====== ====== ====== ====== ======
                                    Bionovo, Inc.
                            (A Development Stage Company)
                             Consolidated Balance Sheets
                        (in thousands, except share amounts)

                                                  September 30,   December 31,
                                                          2009           2008
                                                          ----           ----
                                                      (unaudited)
          ASSETS
    Current assets:
      Cash and cash equivalents                          $2,252        $3,270
      Short-term investments                                 -         10,292
      Receivables                                            56           126
      Prepaid expenses and other current assets             651           805
                                                            ---           ---
        Total current assets                              2,959        14,493
    Property and equipment, net                           6,141         6,938
    Other assets and patent pending, net                  1,349         1,073
                                                          -----         -----
        Total assets                                    $10,449       $22,504
                                                        =======       =======

          LIABILITIES AND SHAREHOLDERS' EQUITY

    Cur
'/>"/>
SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
3. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
4. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
5. Bionovo Announces First Quarter 2009 Highlights and Financial Results
6. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
7. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
8. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
9. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
10. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
11. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015 Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... closing of its previously announced underwritten public offering ... a public offering price of $11.25 per share. ... included 1,000,000 shares issued upon the exercise in ...
(Date:7/31/2015)... SAN DIEGO , July 31, 2015 /PRNewswire/ ... Co., Ltd. (Headquarters: Tokyo , President ... Therapeutics, Inc. (Headquarters: San Diego, California ... "NASDAQ: HALO") have signed a clinical collaboration agreement to ... "eribulin") in combination with Halozyme,s investigational drug PEGPH20 (PEGylated ...
(Date:7/31/2015)... , July 31, 2015 According ... Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray Absorptiometry ... Weighing) - Global Analysis & Forecast to 2019", published ... pegged at $911.1 Million 2014 and is estimated to ... CAGR of 9.4% from 2014 to 2019. ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4
(Date:7/31/2015)... ... August 01, 2015 , ... Super Bowl 50 will emanate from Levi’s Stadium ... day each year is the Super Bowl. In the two weeks that separate the conference ... host venue. The 2016 Super Bowl game will mark the 50th time it has been ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently touted ... in predictive health analytics , Jvion continues to disrupt the predictive analytic ... software that targets patient and population level illness to drive prevention and better ...
(Date:7/31/2015)... ... 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of ... Aesthetics released this new applicator in the United States as an upgrade to the ... The original applicator required a 2 hour treatment time. The new CoolSmooth ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin ... re-branded their social media profiles to better connect with the public. The agency ... find information, share insights and opinions. The Rally Insurance Group, Inc.’s pledge to ...
(Date:7/31/2015)... ... 2015 , ... Ticket Down is a reliable source of authentic Hamilton ... and refreshing show on Broadway, look no further than Hamilton. This American musical is ... Critics Circle Award, Drama Desk Award, Lucille Lortel Award, and New York Drama Critics’ ...
Breaking Medicine News(10 mins):Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7
... SAINT LOUIS, Sept. 24 Accelify announced today ... District (SLPS) voted unanimously to approve the selection of Accelify ... serves approximately 25,000 students making it the largest school district ... Accelify was among a number of companies who responded to ...
... , , WASHINGTON, ... and increased blood pressure in men released yesterday by the ... fructose with high fructose corn syrup, erroneously suggesting that they ... "It is important not to treat studies involving massive ...
... N.J., Sept. 24 Marketing Technology Solutions , ... QualityHealth.com , has today filed a lawsuit alleging that ... misappropriated trade secrets and other confidential information by utilizing MTS-copyrighted online ... a health website owned and operated by MediZine. , , ...
... ... 140 characters or less from change:healthcare , a healthcare technology company. Which is ... proposing. , ... September 24, 2009 -- Starting today, consumers can simply tweet healthcare questions such as "what ...
... , , IRVINE, Calif., Sept. 24 ... the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse ... (GPO) for home care providers, jointly announce a preferred supplier agreement ... SET Pulse Oximeters and sensors. Masimo,s solutions are proven to ...
... , , , ... QRxPharma Limited (ASX: QRX and Pink Sheets: QRXPY), announced ... ("Nuokang"), a Chinese biopharmaceutical company based in Shenyang, China, to ... The strategic alliance involves Nuokang investing US$5.0 million for ...
Cached Medicine News:Health News:Saint Louis Public School District Awards Contract to Accelify 2Health News:Corn Refiners Association Comments on Findings in Recent Report on Sugars and High Blood Pressure 2Health News:MediZine Named in Intellectual Property Lawsuit Filed by Marketing Technology Solutions 2Health News:change:healthcare Announces Twitter Application that brings Healthcare Information and Costs to Consumers' Fingertips 2Health News:change:healthcare Announces Twitter Application that brings Healthcare Information and Costs to Consumers' Fingertips 3Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 2Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 3Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 4Health News:The MED Group Signs Preferred Supplier Agreement for Masimo SET(R) Pulse Oximetry Solutions 5Health News:QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets 2Health News:QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets 3Health News:QRxPharma Announces Strategic Alliance with Liaoning Nuokang Medicines Co Ltd for the Development of Venomics Assets 4
Provides immediate access to comprehensive coverage of more than 325 I.V. drugs, blood products, and solutions....
... a comprehensive, authoritative drug reference to ... overdose management, Canadian drug names, OTC ... drug references and tools is included ... (ED, PRIMARY CARE PLUS, CRC, RN, ...
... patients and health consumers from the trusted ... in MedMaster includes why the medication is ... side effects and warning signs of adverse ... information on what to do if a ...
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Medicine Products: